Nevertheless, despite the tumor suppressive role of ERβ, 17β-estradiol (a potent but unselective agonist of ERα and ERβ) is not used as a therapy against gliomas because long-term treatment can result in cancers of the female reproductive system and prostate cancer in men56,57. This evidence concerns the gene ESR2 and glioma.